AI
Tuesday, September 19, 2017 9:28:18 AM
$RGBP Regen BioPharma President Dr. Harry Lander Our goal in 2018 is to develop an activator and inhibitor of NR2F6 http://ow.ly/IP7230fgAvq
ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
